A derivative of 5-H-indolo[2,3-b]quinoline--a novel liposomally-formulated anticancer agent.
Kociubińska
Anna
A
Institute of Biochemistry and Molecular Biology, University of Wrocław, Przybyszewskiego 63/77, 51-148 Wrocław, Poland.
Gubernator
Jerzy
J
Godlewska
Joanna
J
Stasiuk
Maria
M
Kozubek
Arkadiusz
A
Peczyńska-Czoch
Wanda
W
Opolski
Adam
A
Kaczmarek
Łukasz
Ł
D000970:Antineoplastic Agents / Q000633:toxicity*; D002243:Carbolines / Q000633:toxicity*; D004134:Dimyristoylphosphatidylcholine; D004337:Drug Carriers; D006801:Humans; D008081:Liposomes; D010715:Phosphatidylglycerols; D059005:Topoisomerase II Inhibitors; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D002243:Carbolines; D004337:Drug Carriers; D008081:Liposomes; D010715:Phosphatidylglycerols; D059005:Topoisomerase II Inhibitors; C055575:5,11-dimethyl-5H-indolo(2,3-b)quinoline; C002773:dimyristoylphosphatidylglycerol; D004134:Dimyristoylphosphatidylcholine